Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2026-06-13 @ 6:58 PM
Study NCT ID:
NCT06179303
Status:
RECRUITING
Last Update Posted:
2025-10-06
First Post:
2023-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Sponsor:
University of Washington
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Anatomic Stage III Breast Cancer AJCC v8 | View |
| None | Anatomic Stage IV Breast Cancer AJCC v8 | View |
| None | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | View |
| None | Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma | View |
| None | Metastatic HER2-Negative Breast Carcinoma | View |
| None | Metastatic Hormone Receptor-Positive Breast Carcinoma | View |
Keywords: